Efficacy and Safety of Teneligliptin in Chinese Patients With Type 2 Diabetes Mellitus
Latest Information Update: 10 Apr 2023
At a glance
- Drugs Teneligliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Mitsubishi Tanabe Pharma America
- 11 Nov 2018 Status changed from active, no longer recruiting to completed.
- 06 Jul 2018 Planned primary completion date changed from 1 Jun 2018 to 1 Oct 2018.
- 06 Jul 2018 Status changed from recruiting to active, no longer recruiting.